THE ROLE OF DIGESTIVE MANIFESTATIONS IN COVID-19 MORTALITY: EVIDENCES FROM BRAZIL'S FIRST EPIDEMIC WAVE
Elvis Paim Ferreira1, Mariana da Silva Arbués2, André Castro Lyra1,3
1Faculdade de Medicina da Bahia - UFBA; Salvador, BA, Brasil.
Arquivos De Gastroenterologia
|December 11, 2025
Summary
Gastrointestinal symptoms and liver enzyme abnormalities are key indicators of COVID-19 severity. Diarrhea, elevated liver enzymes, and low albumin levels predict mortality in hospitalized patients.
Area of Science:
- Hepatology
- Infectious Diseases
- Gastroenterology
Background:
- COVID-19 (SARS-CoV-2) primarily causes respiratory illness but also affects the gastrointestinal (GI) tract and liver.
- GI and hepatic manifestations correlate with COVID-19 severity and patient outcomes.
- Understanding these associations is vital for patient management, especially in diverse healthcare systems like Brazil's.
Purpose of the Study:
- To determine the frequency of hepatic and GI injuries in hospitalized COVID-19 patients.
- To analyze the association between these injuries and patient outcomes (discharge or death).
Main Methods:
- A retrospective cross-sectional study of 3,555 hospitalized COVID-19 patients in Brazilian private hospitals (March-December 2020).
- Data collected included demographics, comorbidities, GI symptoms (diarrhea, nausea/vomiting, abdominal pain), liver enzymes (ALT, AST), and outcomes.
- Logistic regression identified predictors of mortality.
Main Results:
- 42.2% of patients had at least one GI symptom; diarrhea was most common (15%).
- Deceased patients showed significantly higher ALT and AST levels, with a higher AST/ALT ratio.
- Diarrhea was linked to lower mortality, while chronic liver disease and hypoalbuminemia predicted death.
Conclusions:
- Hepatic abnormalities and GI symptoms are significant markers of COVID-19 severity.
- Diarrhea, altered liver enzymes, and serum albumin levels are key predictors of mortality.
- Future strategies should include hepatic monitoring, nutritional support, and interventions for high-risk populations.
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
Gastroesophageal Reflux Disease II: Clinical Features and Management
659
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
659
Acute Pancreatitis II: Clinical Manifestations and Management
702
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
702
Regulation of the Digestive System
2.9K
Digestive activity regulation hinges on three primary components. Activation is prompted by a multitude of mechanical and chemical indicators, primarily detected by receptors within the stomach and intestines' walls. These receptors predominantly respond to factors such as mechanical stretching of the organ walls, changes in pH and osmolarity, and the presence of digesting materials and their by-products.
The effectors in this regulation system are glands and smooth muscles. Activation of...
The effectors in this regulation system are glands and smooth muscles. Activation of...
2.9K
What is Monogastric Digestion?
74.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
74.9K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
507
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
507


